These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 4056529)
21. [Clinical significance of sialic acid determinations in patients with gynecologic cancer]. Shimizu Y; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Kurachi K; Okudaira Y Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):49-55. PubMed ID: 3819514 [TBL] [Abstract][Full Text] [Related]
22. [Predictive value of a tumor marker combination for the monitoring of ovarian cancer]. Lahousen M Wien Klin Wochenschr; 1986 May; 98(10):319-25. PubMed ID: 3460273 [TBL] [Abstract][Full Text] [Related]
23. [Measurement of serum tissue polypeptide antigen (TPA) in patients with malignant tumor using prolifigen TPA-M "Daiichi" kit]. Sakahara H; Endo K; Torizuka K; Itoh K; Ohuchi N; Inaba N; Miyaji Y; Takayama M; Ishii K; Takagi H; Konishi J; Fukuoka M; Fukuchi M; Ohkawa J; Kagawa S; Kondo S; Shirouzu K; Iguchi H Gan To Kagaku Ryoho; 1996 May; 23(6):733-43. PubMed ID: 8645025 [TBL] [Abstract][Full Text] [Related]
24. [Serum tissue polypeptide antigen (TPA) in patients with urogenital cancer]. Matsushima M; Kuwabara T; Miyamae K; Hachiya A; Kawahara M; Fukasawa K; Yagishita T; Tajima M; Sawamura Y; Shirai M Hinyokika Kiyo; 1984 Jul; 30(7):869-75. PubMed ID: 6507205 [TBL] [Abstract][Full Text] [Related]
25. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen. Bonfrer JM; Gaarenstroom KN; Korse CM; Van Bunningen BN; Kenemans P Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246 [TBL] [Abstract][Full Text] [Related]
26. [Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer]. Schröck R; Hafter R; Schmid L; Babic R; Ulm K; Gössner W; Graeff H Geburtshilfe Frauenheilkd; 1986 Jan; 46(1):1-10. PubMed ID: 2420679 [TBL] [Abstract][Full Text] [Related]
27. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer]. Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513 [TBL] [Abstract][Full Text] [Related]
28. [The clinical significance of serum tissue polypeptide antigen as a tumor marker for urogenital carcinomas--a comparison with other tumor markers in patients with renal cell carcinoma and prostatic carcinoma]. Yamazaki K; Kumamoto Y; Tsukamoto T; Umehara T; Ohmura K Hinyokika Kiyo; 1987 Oct; 33(10):1581-9. PubMed ID: 2451408 [TBL] [Abstract][Full Text] [Related]
29. [Immunosuppressive acidic protein in patients with gynecologic cancer]. Sawada M; Matsui Y; Okudaira Y; Shimizu Y; Takayama K Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):605-11. PubMed ID: 6408203 [TBL] [Abstract][Full Text] [Related]
30. The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix. Ngan HY; Cheng GT; Yeung WS; Wong LC; Ma HK Gynecol Oncol; 1994 Jan; 52(1):63-8. PubMed ID: 8307503 [TBL] [Abstract][Full Text] [Related]
31. Accuracy of tissue polypeptide specific antigen (TPS) in the diagnosis of ovarian malignancy. Padungsutt P; Thirapagawong C; Senapad S; Suphanit I Anticancer Res; 2000; 20(2B):1291-5. PubMed ID: 10810437 [TBL] [Abstract][Full Text] [Related]
32. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers]. Suzumori K; Yasui Y; Asai H; Hisaoka T; Mizuno K; Yagami Y Gan No Rinsho; 1985 May; 31(5):544-8. PubMed ID: 3860666 [TBL] [Abstract][Full Text] [Related]
33. [Value of CA 125 in comparison to conventional tumor markers in ovarian cancer]. Paulick R; Kaesemann H; Caffier H Geburtshilfe Frauenheilkd; 1986 Aug; 46(8):509-14. PubMed ID: 2875919 [TBL] [Abstract][Full Text] [Related]
34. [Study on the plasma plasminogen activators in patients with malignant gynecologic tumors]. Shimada H; Ikeuchi M; Suwa M; Michimoto T; Ono Y; Tanada S; Himeno K; Hoshino T; Takashima E Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1353-9. PubMed ID: 2511260 [TBL] [Abstract][Full Text] [Related]
35. [Significance of tumor markers in the treatment of patients with ovarian malignancies]. Tomoda Y; Kano T; Furuhashi Y; Mizuno K; Kamiya N; Mizuno K; Sakakibara K; Ohta M Gan To Kagaku Ryoho; 1987 Nov; 14(11):3027-33. PubMed ID: 2445293 [TBL] [Abstract][Full Text] [Related]
36. [Clinical study on tissue polypeptide antigen (TPA) in gastric cancer]. Kanauchi M; Sawai F; Hirayama T; Yumura F; Kanauchi K; Hamaguchi T; Hara Y; Yoshimura K; Nishiura K; Dohi K Gan No Rinsho; 1985 Sep; 31(11):1367-71. PubMed ID: 2999464 [TBL] [Abstract][Full Text] [Related]
37. [Pregnancy-associated alpha 2-glycoprotein in patients with gynecologic cancer]. Sawada M; Matsui Y; Okudaira Y; Shimizu Y; Takayama K Nihon Sanka Fujinka Gakkai Zasshi; 1983 Apr; 35(4):451-8. PubMed ID: 6854093 [TBL] [Abstract][Full Text] [Related]
38. Plasma carcinoembryonic antigen and tissue polypeptide antigen levels in lung cancer: correlation with cell types and stage. Salvati F; Antilli A; Cruciani AR; Pau F; Flore F; Munno R; De Angelis G; Cipri A; Pigorini F Cancer Detect Prev; 1985; 8(1-2):111-4. PubMed ID: 4064030 [TBL] [Abstract][Full Text] [Related]
39. [Tissue polypeptide antigen in gynecological cancer]. Saitoh S; Nakanishi A; Noda T; Yoh S; Ando Y; Moriyama I; Ichijo M Gan No Rinsho; 1985 Jan; 31(1):65-72. PubMed ID: 3981803 [TBL] [Abstract][Full Text] [Related]
40. Serum tumor markers in colorectal cancer staging, grading, and follow-up. Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]